Holmium laser sclerostomy (HLS) was performed in 48 glaucomatous eyes of 46 patients using 5-fluorouracil in 5 doses of 5 mg each in 0.1 mL. This group was compared with a control group of 42 glaucomatous eyes of 41 patients who underwent HLS without 5-fluorouracil. Twenty-eight treated and 24 control eyes needed retreatment. Twelve months after HLS, the success rate in the treated group, in which eyes did not require a second holmium laser treatment, was about 50% vs 33.3% in controls.
USE OF 5-FLUOROURACIL IN AB EXTERNO HOLMIULM LASER SCLEROSTOMY / Pescosolido, Nicola; BOZZONI PANTALEONI, Francesco; D., Giorgi; R., Mollo; R., Bartolini; BALACCO GABRIELI, Corrado. - In: ANNALS OF OPHTHALMOLOGY. - ISSN 1530-4086. - STAMPA. - 32:3(2000), pp. 236-239. [10.1007/s12009-000-0062-x]
USE OF 5-FLUOROURACIL IN AB EXTERNO HOLMIULM LASER SCLEROSTOMY
PESCOSOLIDO, Nicola;BOZZONI PANTALEONI, Francesco;BALACCO GABRIELI, Corrado
2000
Abstract
Holmium laser sclerostomy (HLS) was performed in 48 glaucomatous eyes of 46 patients using 5-fluorouracil in 5 doses of 5 mg each in 0.1 mL. This group was compared with a control group of 42 glaucomatous eyes of 41 patients who underwent HLS without 5-fluorouracil. Twenty-eight treated and 24 control eyes needed retreatment. Twelve months after HLS, the success rate in the treated group, in which eyes did not require a second holmium laser treatment, was about 50% vs 33.3% in controls.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
